These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1010 related items for PubMed ID: 33582141

  • 1. Antimicrobial susceptibility of multidrug-resistant Pseudomonas aeruginosa isolated from drinking water and hospitalized patients in Jordan.
    Tarazi YH, Abu-Basha E, Ismail ZB, Al-Jawasreh SI.
    Acta Trop; 2021 May; 217():105859. PubMed ID: 33582141
    [Abstract] [Full Text] [Related]

  • 2. In vitro activities of antibiotic combinations against clincal isolates of Pseudomonas aeruginosa.
    Chen YH, Peng CF, Lu PL, Tsai JJ, Chen TP.
    Kaohsiung J Med Sci; 2004 Jun; 20(6):261-7. PubMed ID: 15253466
    [Abstract] [Full Text] [Related]

  • 3. In vitro synergy studies with ciprofloxacin and selected beta-lactam agents and aminoglycosides against multidrug-resistant Pseudomonas aeruginosa.
    Meyer RD, Liu S.
    Diagn Microbiol Infect Dis; 1988 Nov; 11(3):151-7. PubMed ID: 3149927
    [Abstract] [Full Text] [Related]

  • 4. In vitro synergistic effect of ciprofloxacin with aminoglycosides against multidrug resistant-Pseudomonas aeruginosa.
    Yasmin F, Akhtar N, Hameed A.
    Pak J Pharm Sci; 2013 Sep; 26(5):1041-4. PubMed ID: 24035966
    [Abstract] [Full Text] [Related]

  • 5. Geographic variations in activity of broad-spectrum beta-lactams against Pseudomonas aeruginosa: summary of the worldwide SENTRY Antimicrobial Surveillance Program (1997-2000).
    Jones RN, Kirby JT, Beach ML, Biedenbach DJ, Pfaller MA.
    Diagn Microbiol Infect Dis; 2002 Jul; 43(3):239-43. PubMed ID: 12106958
    [Abstract] [Full Text] [Related]

  • 6. In vitro efficacy of various antibiotic combinations against Pseudomonas aeruginosa isolates.
    Nazli E, Zer Y, Eksi F.
    J Int Med Res; 2015 Apr; 43(2):217-25. PubMed ID: 25547417
    [Abstract] [Full Text] [Related]

  • 7. Surveillance for antimicrobial susceptibility among clinical isolates of Pseudomonas aeruginosa and Acinetobacter baumannii from hospitalized patients in the United States, 1998 to 2001.
    Karlowsky JA, Draghi DC, Jones ME, Thornsberry C, Friedland IR, Sahm DF.
    Antimicrob Agents Chemother; 2003 May; 47(5):1681-8. PubMed ID: 12709340
    [Abstract] [Full Text] [Related]

  • 8. Cross-resistance of Pseudomonas aeruginosa to ciprofloxacin, extended-spectrum beta-lactams, and aminoglycosides and susceptibility to antibiotic combinations.
    Chow AW, Wong J, Bartlett KH, Shafran SD, Stiver HG.
    Antimicrob Agents Chemother; 1989 Aug; 33(8):1368-72. PubMed ID: 2508546
    [Abstract] [Full Text] [Related]

  • 9. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.
    Timurkaynak F, Can F, Azap OK, Demirbilek M, Arslan H, Karaman SO.
    Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562
    [Abstract] [Full Text] [Related]

  • 10. In-vitro efficacy of synergistic antibiotic combinations in multidrug resistant Pseudomonas aeruginosa strains.
    Dundar D, Otkun M.
    Yonsei Med J; 2010 Jan; 51(1):111-6. PubMed ID: 20046523
    [Abstract] [Full Text] [Related]

  • 11. Trends of Antimicrobial Resistance and Combination Susceptibility Testing of Multidrug-Resistant Pseudomonas aeruginosa Isolates from Cystic Fibrosis Patients: a 10-Year Update.
    Okoliegbe IN, Hijazi K, Cooper K, Ironside C, Gould IM.
    Antimicrob Agents Chemother; 2021 May 18; 65(6):. PubMed ID: 33820772
    [Abstract] [Full Text] [Related]

  • 12. Activity of ceftolozane/tazobactam against a collection of Pseudomonas aeruginosa isolates from bloodstream infections in Australia.
    Henderson A, Tan E, McCarthy KL, Paterson DL.
    Pathology; 2018 Dec 18; 50(7):748-752. PubMed ID: 30392710
    [Abstract] [Full Text] [Related]

  • 13. Common antimicrobial resistance patterns, biotypes and serotypes found among Pseudomonas aeruginosa isolates from patient's stools and drinking water sources in Jordan.
    Shehabi AA, Masoud H, Maslamani FA.
    J Chemother; 2005 Apr 18; 17(2):179-83. PubMed ID: 15920903
    [Abstract] [Full Text] [Related]

  • 14. Activity of levofloxacin and ciprofloxacin in combination with cefepime, ceftazidime, imipenem, piperacillin-tazobactam and amikacin against different Pseudomonas aeruginosa phenotypes and Acinetobacter spp.
    Drago L, De Vecchi E, Nicola L, Colombo A, Guerra A, Gismondo MR.
    Chemotherapy; 2004 Oct 18; 50(4):202-10. PubMed ID: 15452399
    [Abstract] [Full Text] [Related]

  • 15. In vitro efficacy of levofloxacin alone or in combination tested against multi-resistant Pseudomonas aeruginosa strains.
    Flynn CM, Johnson DM, Jones RN.
    J Chemother; 1996 Dec 18; 8(6):411-5. PubMed ID: 8981179
    [Abstract] [Full Text] [Related]

  • 16. In vitro activity of antimicrobial combinations against multidrug-resistant Pseudomonas aeruginosa.
    Santos DA, Nascimento MM, Vitali LH, Martinez R.
    Rev Soc Bras Med Trop; 2013 Dec 18; 46(3):299-303. PubMed ID: 23856877
    [Abstract] [Full Text] [Related]

  • 17. Analysis of resistance, cross-resistance and antimicrobial combinations for Pseudomonas aeruginosa isolates from 1997 to 2009.
    Master RN, Clark RB, Karlowsky JA, Ramirez J, Bordon JM.
    Int J Antimicrob Agents; 2011 Oct 18; 38(4):291-5. PubMed ID: 21737249
    [Abstract] [Full Text] [Related]

  • 18. Antimicrobial resistance, virulence factors, and genotypes of Pseudomonas aeruginosa clinical isolates from Gorgan, northern Iran.
    Shahri FN, Izanloo A, Goharrizi MASB, Jamali A, Bagheri H, Hjimohammadi A, Ardebili A.
    Int Microbiol; 2022 Nov 18; 25(4):709-721. PubMed ID: 35697891
    [Abstract] [Full Text] [Related]

  • 19. Pseudomonas aeruginosa isolated from corneal ulcer: susceptibility to antimicrobial agents tested alone or in combination.
    Hu FR, Luh KT.
    J Formos Med Assoc; 1992 Feb 18; 91(2):190-4. PubMed ID: 1364217
    [Abstract] [Full Text] [Related]

  • 20. Synergistic activities of ceftazidime-avibactam in combination with different antibiotics against colistin-nonsusceptible clinical strains of Pseudomonas aeruginosa.
    Mataraci Kara E, Yilmaz M, İstanbullu Tosun A, Özbek Çelik B.
    Infect Dis (Lond); 2020 Sep 18; 52(9):616-624. PubMed ID: 32427010
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 51.